María
Isidoro García
Profesora Asociada CC. Salud
Mª Belén
García Berrocal
Investigadora desde null
Publicaciones en las que colabora con Mª Belén García Berrocal (16)
2022
-
Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype
Frontiers in Psychiatry, Vol. 12
-
Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy
Pharmaceutics, Vol. 14, Núm. 1
2021
-
A rare HCN4 variant with combined sinus bradycardia, left atrial dilatation, and hypertrabeculation/left ventricular noncompaction phenotype
Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 781-789
-
Economic impact of the application of a precision medicine model (5SPM) on psychotic patients
Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1015-1025
2019
-
Farmacogenómica: la medicina personalizada
Revista del laboratorio clínico, Vol. 12, Núm. 3, pp. 147-154
2018
-
Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients
BMC Medical Genomics, Vol. 11, Núm. 1
-
Usefulness of pharmacogenetic analysis in psychiatric clinical practice: A case report
Clinical Psychopharmacology and Neuroscience, Vol. 16, Núm. 3, pp. 349-357
2017
-
Pharmacogenetics and the treatment of asthma
Pharmacogenomics, Vol. 18, Núm. 13, pp. 1271-1280
2016
-
A systematic in silico approach
Methods in Molecular Biology (Humana Press Inc.), pp. 15-27
-
Impact of new technologies on pharmacogenomics
Current Pharmacogenomics and Personalized Medicine, Vol. 14, Núm. 2, pp. 74-85
-
Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6
Pharmacogenomics, Vol. 17, Núm. 12, pp. 1291-1293
-
Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed with Bipolar Disorder
Medicine (United States), Vol. 95, Núm. 6
2015
-
Primun non nocere, polypharmacy and pharmacogenetics
Pharmacogenomics
2014
-
Characterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test® no-call in the clinical setting
Clinical Chemistry and Laboratory Medicine, Vol. 52, Núm. 6, pp. 799-807
-
Dose reduction of efavirenz: An observational study describing cost-effectiveness, pharmacokinetics and pharmacogenetics
Pharmacogenomics, Vol. 15, Núm. 7, pp. 997-1006
2012
-
Modulation of the serum cytokine expression pattern in hymenoptera allergic patients treated with specific venom immunotherapy
Open Immunology Journal, Vol. 5, Núm. 1, pp. 13-19